Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Interest Expenses (2024)

Tonix Pharmaceuticals Holding has reported Interest Expenses over the past 1 years, most recently at $280000.0 for Q4 2024.

  • Quarterly results put Interest Expenses at $280000.0 for Q4 2024, changed N/A from a year ago — trailing twelve months through Sep 2025 was $280000.0 (down 6.98% YoY), and the annual figure for FY2025 was $89000.0, down 92.79%.
  • Interest Expenses for Q4 2024 was $280000.0 at Tonix Pharmaceuticals Holding, down from $301000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for TNXP hit a ceiling of $301000.0 in Q3 2024 and a floor of $280000.0 in Q4 2024.